Results 131 to 140 of about 8,837 (157)

Non-femoral focused transaxillary access in TAVI: GARY data analysis and future trends. [PDF]

Clin Res Cardiol
Meertens MM, Adam M, Beckmann A, Ensminger S, Frerker C, Seiffert M, Sinning JM, Bekeredjian R, Walther T, Beyersdorf F, Möllmann H, Balaban Ü, Eghbalzadeh K, Rudolph TK, Bleiziffer S.   +14 more
europepmc   +1 more source

Real world federated learning with a knowledge distilled transformer for cardiac CT imaging. [PDF]

NPJ Digit Med
Tölle M, Garthe P, Scherer C, Seliger JM, Leha A, Krüger N, Simm S, Martin S, Eble S, Kelm H, Bednorz M, André F, Bannas P, Diller G, Frey N, Groß S, Hennemuth A, Kaderali L, Meyer A, Nagel E, Orwat S, Seiffert M, Friede T, Seidler T, Engelhardt S.   +24 more
europepmc   +1 more source

Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL. [PDF]

Nat Commun
Arseni L, Sigismondo G, Yazdanparast H, Hermansen JU, Mack N, Ohl S, Kalter V, Iskar M, Kalxdorf M, Friedel D, Rettel M, Paul Y, Ringshausen I, Eldering E, Dubois J, Kater AP, Zapatka M, Roessner PM, Tausch E, Stilgenbauer S, Dietrich S, Savitski MM, Skånland SS, Krijgsveld J, Lichter P, Seiffert M.   +25 more
europepmc   +1 more source

Transcatheter aortic valve implantation in patients with significant septal hypertrophy. [PDF]

Clin Res Cardiol
Beyer M, Demal TJ, Bhadra OD, Linder M, Ludwig S, Grundmann D, Voigtlaender-Buschmann L, Waldschmidt L, Schirmer J, Schofer N, Pecha S, Blankenberg S, Reichenspurner H, Conradi L, Seiffert M, Schaefer A.   +15 more
europepmc   +1 more source

Differential Expression of Immune Checkpoints TIM-3, LAG-3, TIGIT, and Siglec-7 on Circulating Natural Killer Cells - Insights from Healthy Donors Compared to Gastric Cancer Patients.

Oncol Res Treat
Seiffert S, Seiffert S, Blaudszun AR, Shibru B, Körfer J, Köhl U, Fricke S, Sack U, Boldt A.   +8 more
europepmc   +1 more source

Microfluidics-Driven Manufacturing and Multiscale Analytical Characterization of Nanoparticle-Vesicle Hybrids. [PDF]

Adv Healthc Mater
Cardellini J, Normak K, Gerlt M, Makasewicz K, Seiffert C, Capasso Palmiero U, Ye S, González Gómez MA, Piñero Y, Rivas J, Bongiovanni A, Bergese P, Arosio P.   +12 more
europepmc   +1 more source

T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.

Blood
Roessner PM, Seufert I, Chapaprieta V, Jayabalan R, Briesch H, Massoni-Badosa R, Boskovic P, Benckendorff J, Roider T, Arseni L, Coelho M, Chakraborty S, Vaca AM, Sivina M, Muckenhuber M, Rodriguez-Rodriguez S, Bonato A, Herbst SA, Zapatka M, Sun C, Kretzmer H, Naake T, Bruch PM, Czernilofsky F, Ten Hacken E, Schneider M, Helm D, Yosifov DY, Kauer J, Danilov AV, Bewarder M, Heyne K, Schneider C, Stilgenbauer S, Wiestner A, Mallm JP, Burger JA, Efremov DG, Lichter P, Dietrich S, Martin-Subero JI, Rippe K, Seiffert M.   +42 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Sharp power mean bounds for Seiffert mean

Applied Mathematics, 2014
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Yong-Min Li, Miao-Kun Wang, Yu-Ming Chu   +2 more
exaly   +2 more sources

On generalized Seiffert means

Aequationes Mathematicae, 2013
In his previous paper [Aequationes Math. 83, No. 1--2, 191--197 (2012; Zbl 1238.33011)] the author has defined a mean \(X_{k}\) \((0\leq k\leq 1)\) as follows \[ X_{k}\left( x,y\right) =\left[ R_{F}\left( x^{2},y^{2},z^{2}\right) \right] ^{-1}, \] where \[ z=\begin{cases} \sqrt{\left( kx\right) ^{2}+\left( k^{\prime }y\right) ^{2}}\quad \text{if ...
Edward Neuman
exaly   +2 more sources

Refinements of bounds for the arithmetic mean by new Seiffert-like means

AIMS Mathematics, 2021
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Tie-Hong Zhao, Yu-Pei Lv
exaly   +4 more sources